(PDF) P1.04-25 the Implication of Frameshift Mutation

P1.04-25 the Implication of Frameshift Mutation Burden in Neoantigen and Immune Cell Landscape in Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.740

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

MA19.04 the Clinical Implication of Frameshift Indel Mutation Burden in Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.04-03 Suppressive Immune Cell Profiling in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.04-22 CD73 Immunohistochemical Expression in Malignant Cells and Correlation With Immune Infiltrate in Non-Small Cell Lung Carcinoma (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.04-14 HLA B44 Supertype Associated With Less Favorable Neoantigen Binding in Non-Small Cell Lung Cancer Treated With Immunotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine

English

Neutrophils Dominate the Immune Cell Composition in Non-Small Cell Lung Cancer

Nature Communications

Molecular Biology

English

P1.04-31 Efficacy and Tolerance of Immune-Checkpoint Inhibitors in EGFR, ALK/ROS 1 Non-Small-Cell-Lung-Cancer (NSCLC): GFPC 03-2016 IMAD Study

Journal of Thoracic Oncology

Respiratory Medicine

English

MA16.06 EGFR Clonality and Tumor Mutation Burden (TMB) by Circulating Tumor DNA (ctDNA) Sequencing in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.04-17 Tumour Burden as a Predictive Tool of Response to Immune Checkpoint Inhibitors (ICI) in Patients With Metastatic Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English